SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-22-011036
Filing Date
2022-06-01
Accepted
2022-06-01 17:00:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxy2022_add_supporting.htm DEFA14A 52892
2 GRAPHIC img244211780_0.jpg GRAPHIC 6263
  Complete submission text file 0000950170-22-011036.txt   62790
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38503 | Film No.: 22988132
SIC: 2834 Pharmaceutical Preparations